Janssen-Cilag has removed INVOKANA (canagliflozin) from the PBS effective from 1 August 2015. The company was requested by the Department of Health, to either take a significant price reduction of close to 40% on Invokana, or face the medicine being removed from the PBS. A price cut of this magnitude would result in Invokana no
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.